Astellas Completes Acquisition of iota Biosciences
https://www.astellas.com/en/system/files/news/2023-04/20201030_en_1_1.pdf
WebTOKYO October 30, 2020 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that it has completed the acquisition of Iota Biosciences, Inc. (“iota”), a start-up company focused on the bioelectronics field, located in Berkeley, California, and iota has become a wholly owned subsidiary ...
DA: 96 PA: 23 MOZ Rank: 49